[Hydroxylated vitamin D metabolites, therapeutical uses of 1-alpha-hydroxycholecalciferol (author's transl)].
1979
O Vokrouhlická, and
V Horn, and
J Stĕpán, and
V Justová, and
J Erben, and
J Lachmanová, and
V Pacovský
UI
MeSH Term
Description
Entries
D008297
Male
Males
D008875
Middle Aged
An adult aged 45 - 64 years.
Middle Age
D012080
Chronic Kidney Disease-Mineral and Bone Disorder
Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D005260
Female
Females
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887
Hydroxycholecalciferols
Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3.
Hydroxyvitamins D,Hydroxycholecalciferol
D000328
Adult
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
Adults
Related Publications
O Vokrouhlická, and
V Horn, and
J Stĕpán, and
V Justová, and
J Erben, and
J Lachmanová, and
V Pacovský
January 1993,
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
O Vokrouhlická, and
V Horn, and
J Stĕpán, and
V Justová, and
J Erben, and
J Lachmanová, and
V Pacovský